Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
$863K Sell
31,624
-1,625
-5% -$49.1K ﹤0.01% 2016
2025
Q2
$963K Buy
33,249
+1,144
+4% +$32.4K ﹤0.01% 1966
2025
Q1
$922K Buy
32,105
+14,697
+84% +$555K 0.01% 1862
2024
Q4
$780K Buy
+17,408
New +$822K ﹤0.01% 1948
2024
Q3
Sell
-19,632
Closed -$758K 3082
2024
Q2
$758K Sell
19,632
-12,485
-39% -$513K 0.01% 1909
2024
Q1
$1.57M Buy
32,117
+11,818
+58% +$567K 0.01% 1823
2023
Q4
$982K Buy
20,299
+14,251
+236% +$635K 0.01% 2071
2023
Q3
$246K Buy
+6,048
New +$240K ﹤0.01% 2686
2022
Q3
Sell
-10,913
Closed -$313K 4473
2022
Q2
$313K Buy
10,913
+4,944
+83% +$188K ﹤0.01% 3404
2022
Q1
$309K Buy
5,969
+354
+6% +$18.2K ﹤0.01% 2827
2021
Q4
$377K Sell
5,615
-48,743
-90% -$3.51M ﹤0.01% 2644
2021
Q3
$3.97M Buy
+54,358
New +$4M 0.05% 582
2021
Q2
Sell
-11,795
Closed -$507K 2946
2021
Q1
$507K Buy
+11,795
New +$583K 0.01% 1945

Other funds holding DCBO

Cubist Systematic Strategies's DCBO Position: Q3 2025 in Review

Cubist Systematic Strategies reduced its Docebo (DCBO) stake by 4.9% in Q3 2025, selling an estimated $49.1K and leaving 31,624 shares worth $863K. The position accounts for ﹤0.01% of the portfolio, ranked #2016.

Cubist Systematic Strategies first reported a position in DCBO in Q1 2021 and has held it in 13 quarters since. The position peaked at $3.97M in Q3 2021. 89 funds tracked by Wall St. Rank hold DCBO as of Q3 2025.

  • Cubist Systematic Strategies held 31,624 shares of Docebo worth $863K as of Q3 2025.
  • Cubist Systematic Strategies sold 1,625 Docebo shares in Q3 2025, an estimated $49.1K.
  • Docebo made up ﹤0.01% of Cubist Systematic Strategies's portfolio in Q3 2025, its #2016 holding.
  • Cubist Systematic Strategies first reported a position in Docebo in Q1 2021 and has held it in 13 quarters since.
  • Cubist Systematic Strategies's Docebo position peaked at $3.97M in Q3 2021.
  • 89 funds tracked by Wall St. Rank held Docebo as of Q3 2025.

Based on Cubist Systematic Strategies's 13F filing for Q3 2025, filed 14 Nov 2025.